Edition:
India

Acer Therapeutics Reports Second Quarter Loss Per Share $1.09


Wednesday, 14 Aug 2019 

Aug 13 (Reuters) - Acer Therapeutics Inc ::ACER THERAPEUTICS REPORTS SECOND QUARTER 2019 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE.Q2 LOSS PER SHARE $1.09.Q2 EARNINGS PER SHARE ESTIMATE $-0.78 -- REFINITIV IBES DATA.CASH AND CASH EQUIVALENTS WERE $23.5 MILLION AS OF JUNE 30, 2019, COMPARED TO $41.7 MILLION AS OF DECEMBER 31, 2018.